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Abstract
Background: According to the latest Tanzanian National AIDS Control Programme (NACP) report a total of
147,271 individuals donated blood during the year 2002. However, blood safety remains an issue of major concern
in transfusion medicine in Tanzania where national blood transfusion services and policies, appropriate
infrastructure, trained personnel and financial resources are inadequate. Most of the donated blood is screened
for HIV alone.
Methods: We determined among blood donors at Muhimbili National Hospital (MNH), the seroprevalence of
human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B surface antigen (HBsAg) and syphilis by
donor type, sex and age and to determine association, if any, in the occurrence of the pathogens. The sample
included 1599 consecutive donors, 1424(89.1%) males and 175 (10.9%) females, who donated blood between
April 2004 and May, 2005. Most of them 1125 (70.4%) were replacement donors and a few 474 (29.6%) voluntary
donors. Their age (in years) ranged from 16 to 69, and most (72.2%) were between 20–39 years.
Results: Two hundred and fifty four (15.9%) of the donated blood had serological evidence of infection with at
least one pathogen and 28 (1.8%) had multiple infections. The current seroprevalence of HIV, HBsAg, HCV and
syphilis among blood donors at MNH in Dar es Salaam was found to be 3.8%, 8.8%, 1.5% and 4.7%, respectively.
Respective seroprevalences among HIV seronegative blood donors were 8.7% for HBV, 1.6% for HCV and 4.6%
for syphilis. The differences in the prevalence of HIV and syphilis infections between replacement and voluntary
donors were statistically significant (P < 0.05). Syphilis was the only infection that occurred more frequently
among HIV infected (12.1%) than non-infected (4.6%) blood donors (P < 0.05), and whose prevalence increased
with age (X2 = 58.5 df = 5, P < 0.001). There were no significant sex differences in the occurrence of pathogens.
Finally, there were significant associations in the occurrence of HBsAg and syphilis (OR = 2.2, 95% CI 1.1.-4.2)
and HIV and syphilis (OR = 2.2, 95% CI 1.0–5.3).
Conclusion: The high (15.9%) seroprevalence of blood-borne infections in blood donated at MNH calls for
routine screening of blood donors for HBV, HCV, HIV and syphilis and for strict selection criteria of donors, with
emphasis on getting young voluntary donors and for establishment of strict guidelines for blood transfusions.
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Background
The demand for blood transfusion services in Tanzania is
high due to endemicity of infections causing anemia, mal-
nutrition, and surgical and obstetrical emergencies associ-
ated with blood loss [1,2]. According to the latest
National AIDS Control Programme (NACP) report a total
of 147,271 individuals donated blood during the year
2002 [1]. However, blood safety remains an issue of
major concern in transfusion medicine in Tanzania where
national blood transfusion services and policies, appro-
priate infrastructure, trained personnel and financial
resources are inadequate. This is aggravated by the pre-
dominance of family and replacement, rather than regular
benevolent, non-remunerated donors and lack of compre-
hensive and systematic screening of donated blood for
transfusion-transmissible agents other than HIV. All
blood transfusion centres in Tanzania screen donor blood
for HIV alone. Other main transfusion transmissible
infections such as Hepatitis B and C, malaria, and syphilis
are not routinely screened. As a result, some of the blood
being transfused is likely to contain unscreened patho-
gens.
Limited information exists regarding the magnitude of
blood-borne pathogens in HIV seronegative donor blood.
In a pilot study that we conducted at Muhimbili National
Hospital (MNH) in Dar es Salaam in 1999 among 300
blood donors, the overall frequency of anti-HIV, anti-
HCV, anti-HBs, HBsAg, anti-HTLV-1, and syphilis anti-
bodies were 8.7%, 8%, 20%, 11%, 0%, and 12.7%,
respectively [3]. Among the HIV seronegative donors, the
frequency of anti-HCV, anti-HBsAg, HBsAg, anti-HTLV-1,
and syphilis antibodies were 8.8%, 22%, 11%, 0%, and
10.9%, respectively. HIV-seropositive donors had an
increased risk for being positive for syphilis antibodies
and HBsAg, but not anti-HCV, anti-HBsAg or anti-HTLV-
1.
However, six years have elapsed since the last study of
blood-borne pathogens was conducted [3]. During this
time the prevalence of HIV as well as that of HCV, HBsAg,
and T pallidum, which share common modes of transmis-
sion with HIV, are likely to have changed. This scenario is
likely to change the risk of transmitting blood-borne path-
ogens since donor blood is not screened comprehensively
for all common blood-borne pathogens. Thus, it is pru-
dent to quantify the risk of blood borne infections associ-
ated with such transfusions at regular intervals. In the
previous study [3], only a relatively small number of
donors was involved (n = 300) and for some investiga-
tions such as HCV and HBsAg only 100 donor blood sam-
ples were screened due to lack of resources. As a result, the
data generated was rather limited. For example, it was not
possible to estimate the seroprevalence of the different
infections by donor type (replacement or voluntary
donor), yet this is thought to be very important informa-
tion since the prevalence of blood borne pathogens may
differ significantly with donor category [4,5]. Further-
more, the small sample size might have undermined the
associations in the occurrences of the pathogens. For
example, the association between HIV and HCV which
was found to be marginally non-significant could have
been significant with a larger sample. Since the publica-
tion showing the prevalence of HCV to be 8% [3] con-
cerns have been raised about the accuracy of the latex
agglutination technique employed in that study. It has
been argued that the presented estimate could have been
an overrepresentation of the situation emanating from
cross-reactivity. More accurate HCV tests have now been
developed and are widely available such as enzyme-linked
immunosorbent assay (ELISA), radioimmunoassay (RIA)
and polymerase chain reaction (PCR). Finally, it is inter-
esting to find out the prevalence of HBsAg, HCV and syph-
ilis infections in HIV seronegative blood, which is
normally transfused to the needy patients.
Thus, the objective of this study was to determine, among
blood donors at MNH, the seroprevalence of HIV, HCV,
HBsAg, and syphilis by donor type, sex and age and to
determine association, if any, in the occurrence of infec-
tion with the respective pathogens.
Methods
Study design and setting
This was a cross sectional study which was carried out in
the Departments of Hematology and Blood Transfusion
and Microbiology and Immunology in MNH and Muhim-
bili University College of Health Sciences (MUCHS) in
Dar es Salaam between April 2004 and May, 2005.
Study population
A consecutive sample of 1559 apparently healthy adult
voluntary (motivated blood donor, who donates at regu-
lar intervals) and replacement (usually one time blood
donor only when a relative is in need of blood) blood
donors agreed to participate after an informed consent.
Individuals who were included in the study were healthy
men and non-pregnant non lactating women aged
between 18 and 69 years, weighing ≥ 50 kg and with
hemoglobin levels above 12.5 g/d1 for females and 13.5
g/d1 for males. Exclusion criteria included: current history
of medication and those with a history of operation, seri-
ous illness, jaundice, blood transfusion, radiotherapy or
any form of cancer therapy. These selection procedures are
done routinely in the blood transfusion unit of the depart-
ment of Hematology and Blood Transfusion, MNH.
Specimens
Blood samples were collected aseptically in 5 ml red top
vacutainers (BD, NJ, USA) and left to clot. Sera specimensBMC Public Health 2006, 6:21 http://www.biomedcentral.com/1471-2458/6/21
Page 3 of 6
(page number not for citation purposes)
were separated after centrifugation, aliquoted into 2 ml
cryotubes tubes (Nalge Nunc International, IL, USA) and
stored at -20°C until the time for assay.
Assays
HIV serology
HIV status was determined by Vironostika HIV Uni-Form
II Ag/Ab (BioMerieux, Boxtel, The Netherlands) and reac-
tive samples were retested by Vironostika HIV Uni-Form II
Plus O (BioMerieux, Boxtel, The Netherlands). These
assays detect both HIV-1/2 infections. Samples reactive on
both tests were considered to be positive for IgG anti HIV
antibodies.
HCV serology
IgG antibodies to HCV were detected using an ELISA tech-
nique (Murex anti-HCV version 4.0). This involved inoc-
ulation of diluted sample on microwells coated with
highly purified antigens which contained sequences from
the core, NS3, NS4 and NS5 regions of HCV. The amount
of conjugate bound, and hence colour, in the wells, is
directly related to the concentration of antibody in the
sample. When the test is run and results are interpreted
according to manufacturer's instructions high sensitivity
(99.93%) and specificity (99.82%) are achieved.
Syphilis serology
Syphilis was diagnosed using VDRL (Murex Diagnostics,
Kent, UK) and Treponema pallidum Hemagglutination
(TPHA) (Fujirebio, Tokyo, Japan). Active syphilis was
diagnosed if an individual's blood became positive on
both tests.
Detection of hepatitis B surface antigen (HBsAg)
HBsAg Version 3.0, an immunoassay, was used for the
detection of hepatitis B surface antigen (HBsAg)). The test
has sensitivity and specificity of approximately 99.7% and
99.3%, respectively when performed according to the
instructions of the manufacturer (Murex Biotech Ltd,
Dartford, UK).
Statistical analysis
Data were coded, entered, cleaned, validated and analysed
using SPSS version 12.0 [6]. The seroprevalence of HIV,
HCV, HBsAg and syphilis was expressed in percentages for
the entire study group and by age, sex and donor category
and comparisons between the groups were done using
Pearson Chi-Square. Logistic regression was used to deter-
mine the associations between the occurrence of HIV,
HCV, HBsAg and syphilis after controlling for age and sex.
The associations are presented as odds ratio (OR) together
Table 1: Age, sex, donor category and test results of the individuals who donated blood (n = 1599)
Number tested and percentage seropositive
Total sample HIV HBsAg HCV Syphilis
Age
16–19 109 (7.0%) 107 (2.8%) 109 (8.3%) 109(3.7%) 109(0.0%)
20–29 629 (40.3%) 611 (2.3%) 629(9.2%) 628(0.6%) 629(2.1%)
30–39 497 (31.9%) 487(4.7%) 496(9.7%) 497(2.2%) 495(5.7%)
40–49 234 (15.0%) 224(6.3%) 234(7.3%) 234(1.7%) 234(6.8%)
50–59 78(5.0%) 76(6.6%) 78(10.3%) 78(1.3%) 78(19.2%)
60–69 12(0.8%) 12(0.0%) 12(8.3%) 12(0.0%) 12(16.7%)***
Sex
Males 1424 (89.1%) 1422(3.8%) 1423(9.1%) 1424(1.5%) 1422(4.8%)
Females 175 (10.9%) 175(4.0%) 175(6.3%) 174(1.1%) 175(4.0%)
Donor category
Replacement donors 1125 (70.4%) 1116(4.5)* 1124(9.5%) 1125(1.8%) 1123(6.1%)*
Voluntary donors 474 (29.6%) 441(2.0%) 474(7.2%) 473(0.8%) 474(1.5%)
HIV serostatus
HIV seropositive donors 58(8.6%) 0(0.0%) 58(12.1%)**
HIV seronegative donors 1495(8.7%) 1572(1.6%) 1494(4.6%)
Total 1599 (100%) 1557(3.8%) 1598(8.8%) 1597(1.5%) 1597(4.7%)
Test results are not available for all donors
*Significantly higher prevalence among replacement donors (P < 0.05)
**Significantly higher prevalence among HIV seropositive donors (P < 0.05)
*** Significant age differences in the prevalence of syphilis (P < 0.0001)BMC Public Health 2006, 6:21 http://www.biomedcentral.com/1471-2458/6/21
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with 95% confidence intervals (C1) and were considered
to be significant if the corresponding 95% C1 did not
include one.
Ethical issues
A written informed consent was obtained prior to enroll-
ment. The following information was given during donor
education to ensure that donors have the information
needed to make an informed choice; a complete descrip-
tion of the aims of the study, infectious agents that were
being screened, potential benefits and risks, blood collec-
tion procedures and assurance of confidentiality of any
information given as well as test results. Any other
requested additional information was provided to donors
by study personnel. Donors who were found have any of
the screened pathogens were refereed to the Department
of Internal Medicine of the Muhimbili National Hospital
where additional investigations and appropriate manage-
ment and follow-up were given. All donor information
and test results were confidentially kept.
Results
The study recruited a total of 1599 donors, 1424(89.1%)
males and 175 (10.9%) females. Most of them 1125
(70.4%) were replacement donors and a few 474 (29.6%)
voluntary donors. Their ages (in years) ranged from 16 to
69, mostly (72.2%) were between 20–39 years (Table 1).
Two hundred and fifty four (15.9%) of the donated blood
had serological evidence of infection with at least one
pathogen and 28 (1.8%) had multiple infections. The
multiple infections were mostly HBsAg and syphilis, and
HIV and syphilis (Table 2). One donor had evidence of
infection with HBV, syphilis and HIV. The overall preva-
lence of HIV, HBsAg, HCV and syphilis were 3.8%, 8.8%,
1.5%, and 4.7%, respectively. The prevalence of syphilis
increased with age (X2 = 58.5 df = 5, P < 0.001). There were
no significant sex differences. The prevalence of HIV,
HBsAg, HCV and syphilis among replacement donors
were 4.5%, 9.5%, 1.8% and 6.1%, respectively, while in
voluntary donors it was 2.0%, 7.2%, 0.8% and 1.5%,
respectively. The differences in the prevalence of HIV and
syphilis infections between replacement and voluntary
donors were significantly (P < 0.05) (Table 1). The HBsAg
and HCV were also more prevalent among replacement
donors but the difference was not statistically significant.
The prevalence of HBsAg, HCV and syphilis among HIV
infected donors was 8.6%, 0.0%, and 12.1%, respectively,
compared with 8.7%, 1.6% and 4.6% for HIV-seronega-
tive donors. Only syphilis occurred more frequently
among HIV seropositive (12.1%) than HIV seronegative
(4.6%) donors (P non-infected individuals (P < 0.05)
(Table 1). There were statistically significant associations
in the occurrence of HBsAg and syphilis OR = 2.2 (95%CI:
1.1–4.2) and HIV and syphilis OR = 2.2 (95%CI: 1.0–
5.3).
Discussion
The aim of this study was to determine the seroprevalence
of HIV, HBsAg, HCV and syphilis among blood donors at
MNH in Dar es Salaam, by donor type, age, and sex and to
determine association if any, in occurrence of the patho-
gen as well as potential risk of HBsAg, HCV and syphilis
infection associated with HIV seronegative blood transfu-
sion. Most of the donor were males 1424 (88.4%), aged
between 20–39 years (72.2%) and were mainly replace-
ment 1125 (69.8%) rather than voluntary donors 474
(29.4%), which is consistent with observations in several
other studies in Africa [7-9]. This study showed that
15.9%, (~one out six), of the donated blood was seropos-
itive for at least one of the screened pathogens, which is
very high prevalence that calls for strict screening of
donated blood and stringent donor selection criteria [4].
It was also noted that 28 (1.8%) of donated blood had
serological evidence of multiple infections, most fre-
quently HBsAg and syphilis followed by HIV and syphilis.
These three pathogens are the commonest in this donor
population and should be always screened for as a matter
of priority.
The overall seroprevalence of antibodies against HIV,
HBsAg, ant HCV and syphilis were 3.8%, 8.8%, 1.5% and
4.7%, respectively. These figures compared well with
those reported in other parts of Africa [4,5,15-17].
Results this study when compared with those of a study
conducted in 1999 at the same hospital, which found the
prevalence of HIV, HBsAg, HCV and syphilis to be 8.7%,
11.0%, 8% and12.7% respectively [3], represent a reduc-
tion in all the screened pathogens, especially HCV and
syphilis. The reduction in HIV seem to fit a pattern
Table 2: Association in the occurrence of HBsAg, HIV, HBV and syphilis determined by logistic regression after adjusting for age and 
sex and expressed as odds ratio (OR) with 95 percentage confidence interval (95% CI)
Infections N % Crude OR(95% CI) Adjusted OR (95% CI)
HBsAg and HIV 5 17.9 1.0(0.4–2.5) 1.0(0.4–2.5)
HBsAg and syphilis 11 39.3 2.1(1.1–4.0) 2.2(1.1–4.2)
HIV and syphilis 7 25 2.9(1.3–6.6) 2.2(1.0–5.3)
HCV and syphilis 2 7.1 0.9(0.1–6.6) 0.9 (0.1–6.8)
HBsAg and HCV 2 7.1 0.9(0.2–4.3) 0.9 (0.2–3.9)BMC Public Health 2006, 6:21 http://www.biomedcentral.com/1471-2458/6/21
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reported by NACP showing a decrease of HIV infections
among blood donors from 33% in 1999 to 10% in 2003
[1]. This could be due to increased self-selection of indi-
viduals donating blood, which has been associated with a
reduction of number of donors per month, both replace-
ment and voluntary donors, from 744 in 1999 to 495 in
2005 (unpublished observation), which may also explain
the reduction in the seroprevalence of HBsAg and syphilis.
It is possible that behavioural change, in particular in the
youth Tanzania population, may have contributed to the
observed decline in the prevalence of HIV and other STIs
as suggested by others [18,19]. The high prevalence of
HCV reported in 1999 was possibly due to the latex tech-
nique used for diagnosis, which has since been found to
be unreliable due cross- reactivity giving rise to false posi-
tive reactivities [3]. The current prevalence of HCV found
in the present study is in keeping with findings in other
parts of Africa, showing a range of between 0.2% and
3.0% [4,10,11].
The prevalence of HIV and syphilis among replacement
donors was significantly higher than that found in volun-
tary donors, being 4.5% versus 2.0% for HIV, and 6.1%
versus 1.5% for syphilis. A similar tendency was also
noted for HBsAg and (9.5% versus 7.5%) for HBsAg, and
HCV 2.0% versus 0.8%, though the differences were not
statistically significant. These results, which are in keeping
with those of other studies [8-10], strongly indicate that
replacement donors are less suitable and that major
emphasis should be made to encourage voluntary donors.
It is extremely important to note the high prevalence of
HBsAg (8.7), HCV (1.6%) and syphilis (4.6%) and
among HIV seronegative blood, which is normally
deemed, fit for transfusion. These figures, which can be
utilized to estimate the risk of transfusion associated
transmission HBV, HCV and syphilis, should serve as a
remainder to health personnel to take the necessary pre-
cautions, including reducing the number of unnecessary
transfusions [2,12].
With regard to the occurrence of the pathogens, there were
significant associations between HIV and syphilis and
syphilis and HBsAg (Table 2). These could be due to the
fact that these pathogens are sexually transmitted, espe-
cially syphilis which has lesions that promote transmis-
sion of HIV infection [13]. The lack of association of the
pathogens with HCV could lend support to the argument
that this virus is not efficiently transmitted by sexual inter-
course, and its epidemiology, in the studied donor popu-
lation is not linked to that of HIV, HBV or syphilis.
Previous studies in Tanzania have not been able to depict
the modes of HCV transmission in this country [3,14], a
gap that warrants further studies.
Conclusion
This high (15.9%) seroprevalence of transfusion-trans-
missible infections in blood donated at MNH is alarming
and calls for i) comprehensive screening of donor blood
for HIV, HBV, HCV and syphilis ii) strict selection of
donors, with emphasis on getting young voluntary non-
remunerated donors rather than replacement donors, iii)
establishment of strict guidelines for blood transfusions
and iv) search for viral co-infections in HIV infected
patients.
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